G2 Goldfields Significantly Increases Gold Ounces in an Updated Mineral Resource Estimate at the Oko Project in Guyana
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSXV: GTWO; OTCQX: GUYGF) is pleased […]
Digihost Announces 2023 Year End Financial Results and Provides Operational Update
HOUSTON, April 03, 2024 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (Nasdaq: DGHI; TSXV: DGHI), an innovative […]
Mayfair Acquisition Corp. Announces Change to Board of Directors
VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) — Mayfair Acquisition Corp. (TSXV: MFA.P) (“Mayfair” or the “Company“) announces that […]
DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors
BROSSARD, Quebec, April 02, 2024 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a […]
Hampton Financial Corporation Closes Its Acquisition of Oxygen Working Capital Corp.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 02, 2024 (GLOBE NEWSWIRE) […]
EnWave Signs Technology Evaluation and License Option Agreement with Food Company Led by Michelin Star Chef
VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced […]
NurExone Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Company Update
TORONTO and HAIFA, Israel, April 02, 2024 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or […]
SONORO GOLD CLOSES OVER-SUBSCRIBED $1 MILLION NON-BROKERED PRIVATE PLACEMENT
VANCOUVER, Canada, April 02, 2024 (GLOBE NEWSWIRE) — Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” […]
Bitcoin Well Announces BTC Sessions Partnership
EDMONTON, Alberta, April 02, 2024 (GLOBE NEWSWIRE) — Bitcoin Well Inc. (“Bitcoin Well” or the “Company”) (TSXV: BTCW; OTCQB: BCNWF), […]
Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), […]
